These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32599666)

  • 1. Treatment of recurrent urinary tract infections in a 60-year-old kidney transplant recipient. The use of phage therapy.
    Rostkowska OM; Międzybrodzki R; Miszewska-Szyszkowska D; Górski A; Durlik M
    Transpl Infect Dis; 2021 Feb; 23(1):e13391. PubMed ID: 32599666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology.
    Espinar MJ; Miranda IM; Costa-de-Oliveira S; Rocha R; Rodrigues AG; Pina-Vaz C
    PLoS One; 2015; 10(8):e0134737. PubMed ID: 26237422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Dutch Case Report of Successful Treatment of Chronic Relapsing Urinary Tract Infection with Bacteriophages in a Renal Transplant Patient.
    Kuipers S; Ruth MM; Mientjes M; de Sévaux RGL; van Ingen J
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary Tract Infections Caused by
    Krawczyk B; Wysocka M; Michalik M; Gołębiewska J
    Front Cell Infect Microbiol; 2022; 12():861374. PubMed ID: 35531341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of Gastrointestinal Carriage of Klebsiella Pneumoniae-Producing Extended-Spectrum Beta-Lactamases in Kidney Graft Recipients.
    Wilkowski P; Gajko K; Marczak M; Hryniewiecka E; Wojtowicz M; Dobrzaniecka K; Mlynarczyk G; Paczek L; Ciszek M
    Transplant Proc; 2018; 50(6):1874-1877. PubMed ID: 30056919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.
    Brizendine KD; Richter SS; Cober ED; van Duin D
    Antimicrob Agents Chemother; 2015 Jan; 59(1):553-7. PubMed ID: 25385105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Treatment of Urinary Tract Infection in Kidney Transplant Recipients Caused by Multiresistant Klebsiella pneumoniae Producing New Delhi Metallo-Beta-Lactamase (NDM-1) With Strains Genotyping.
    Wilkowski P; Ciszek M; Dobrzaniecka K; Sańko-Resmer J; Łabuś A; Grygiel K; Grochowiecki T; Młynarczyk G; Pączek L
    Transplant Proc; 2016 Jun; 48(5):1576-9. PubMed ID: 27496450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections Due to Extended-Spectrum Beta-Lactamase (ESBL)-Producing Klebsiella pneumoniae.
    Wilkowski P; Hryniewiecka E; Jasińska K; Pączek L; Ciszek M
    Ann Transplant; 2023 May; 28():e939258. PubMed ID: 37190675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-spectrum beta-lactamase
    Vachvanichsanong P; McNeil EB; Dissaneewate P
    Epidemiol Infect; 2020 Dec; 149():e12. PubMed ID: 33327984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Han SB; Lee SC; Lee SY; Jeong DC; Kang JH
    BMC Infect Dis; 2015 Oct; 15():414. PubMed ID: 26464143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
    Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R
    BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients.
    Freire MP; Abdala E; Moura ML; de Paula FJ; Spadão F; Caiaffa-Filho HH; David-Neto E; Nahas WC; Pierrotti LC
    Infection; 2015 Jun; 43(3):315-23. PubMed ID: 25690848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESBL-producing enterobacteriaceae-related urinary tract infections in kidney transplant recipients: incidence and risk factors for recurrence.
    Pilmis B; Scemla A; Join-Lambert O; Mamzer MF; Lortholary O; Legendre C; Zahar JR
    Infect Dis (Lond); 2015; 47(10):714-8. PubMed ID: 26024285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is multiresistant Klebsiella pneumoniae New Delhi metallo-beta-lactamase (NDM-1) a new threat for kidney transplant recipients?
    Karczewski M; Tomczak H; Piechocka-Idasiak I; Cichanska L; Adamska Z; Stronka M
    Transplant Proc; 2014 Sep; 46(7):2409-10. PubMed ID: 25242796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host and pathogen factors in Klebsiella pneumoniae upper urinary tract infections in renal transplant patients.
    Gołębiewska JE; Krawczyk B; Wysocka M; Ewiak A; Komarnicka J; Bronk M; Rutkowski B; Dębska-Ślizień A
    J Med Microbiol; 2019 Mar; 68(3):382-394. PubMed ID: 30747620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
    Rodríguez-Avial C; Rodríguez-Avial I; Merino P; Picazo JJ
    Clin Microbiol Infect; 2012 Jan; 18(1):61-6. PubMed ID: 21722259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Potential of Intravenous Phage as Standalone Therapy for Recurrent Drug-Resistant Urinary Tract Infections.
    Le T; Nang SC; Zhao J; Yu HH; Li J; Gill JJ; Liu M; Aslam S
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0003723. PubMed ID: 36975787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant
    Bao J; Wu N; Zeng Y; Chen L; Li L; Yang L; Zhang Y; Guo M; Li L; Li J; Tan D; Cheng M; Gu J; Qin J; Liu J; Li S; Pan G; Jin X; Yao B; Guo X; Zhu T; Le S
    Emerg Microbes Infect; 2020 Dec; 9(1):771-774. PubMed ID: 32212918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.
    Boix-Palop L; Xercavins M; Badía C; Obradors M; Riera M; Freixas N; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
    Int J Antimicrob Agents; 2017 Aug; 50(2):197-202. PubMed ID: 28552471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.